Comprehensive implementation of the "three systems" of administrative law enforcement
Source: Hubei Food and Drug Administration recently, in order to implement the State Council's "Guiding Opinions on the Comprehensive Implementation of the Administrative Enforcement Publicity System, the Enforcement Process, the Enforcement Process, and the Enforcement of the Entire Process Recording System for Major Enforcement Decisions." (Guobanfa  No. 118), further Promote the construction of a government under the rule of law in the field of drug supervision, and effectively regulate administrative law enforcement behaviors. The State Food and Drug Administration has issued the National Drug Administration
Provincial Bureau convened the theme education mobilization deployment meeting of "Don't forget the original intention and keep the mission in mind"
Source: In the morning of June 14th, the Food and Drug Administration of Hubei Province, the provincial bureau held a theme education mobilization deployment meeting of "Don't forget the original heart and keep the mission in mind". Deng Xiaochuan, Secretary of the Party Committee of the Bureau, Director, and Leader of the Leading Group on Theme Education, attended and gave a mobilization speech. He emphasized that party organizations at all levels and all party members and cadres at all levels must thoroughly study and implement the spirit of General Secretary Xi Jinping's important speech, and conscientiously implement the Party Central Committee ’s general requirements, goals, tasks, and methods for thematic education.
The State Drug Administration released the "Annual Report on Drug Supervision Statistics for 2018"
Source: Medicine Net, Medicine Economic News, Medicine Net, May 10th. On May 9, the State Drug Administration officially released the “Annual Report on Drug Supervision Statistics for 2018”. The report shows that in 2018, a total of 312 clinical trials of new drugs were approved, 25 new drug certificates and approval numbers for new drug production were approved, and 10 approval numbers were approved; 8 clinical applications were approved in accordance with the new drug application procedures; 58 clinical applications for generic drugs were approved Pieces, production applications
New Year's speech 丨 Reform, opening up, start again
Source: State Food and Drug Administration. We have bid farewell to the challenging and promising 2018 with the glorious achievements of the 40 years of reform and opening up, and welcome the promising and promising 2019 with the ambition of starting from reform and opening up. At this moment of resigning from the old and welcoming the new, we extend our best wishes to the cadres, staff and relatives of the national drug regulatory system! Heartfelt thanks to friends from all walks of life who care about and support drug supervision
State Food and Drug Administration requires comprehensive strengthening of quality management of winning varieties
Source: China Medicine News On December 27, the State Drug Administration issued the "Notice on Strengthening Drug Supervision Work during the Centralized Drug Procurement and Use Pilot Period" (hereinafter referred to as the "Notice"), requiring drug regulatory authorities at all levels to fully implement the Party Central Committee. 2. The State Council ’s important decision-making arrangements and the work requirements of the “National Organization's Pilot Scheme on Centralized Drug Procurement”, with supervision over inspections and product sampling as the starting point, to strengthen the full-cycle quality of the production, circulation and use of the winning products.